The comparative safety of analgesics in older adults with arthritis.
暂无分享,去创建一个
J. Rassen | S. Schneeweiss | R. Glynn | D. Solomon | R. Levin | Joy L. Lee
[1] T. Huizinga,et al. The comparative safety of analgesics in older adults with arthritis: Commentary , 2011 .
[2] M. Egger,et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis , 2011, BMJ : British Medical Journal.
[3] Jing Jing Li,et al. A randomized, controlled trial of early versus late initiation of dialysis. , 2010, The New England journal of medicine.
[4] L. Køber,et al. Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals , 2010, Circulation. Cardiovascular quality and outcomes.
[5] A. Friedman,et al. Reassessment of albumin as a nutritional marker in kidney disease. , 2010, Journal of the American Society of Nephrology : JASN.
[6] Benedikt Fischer,et al. Deaths related to the use of prescription opioids , 2009, Canadian Medical Association Journal.
[7] L. Shaw,et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. , 2009, Kidney international.
[8] M. Joffe. Exhaustion, automation, theory, and confounding. , 2009, Epidemiology.
[9] J. Avorn,et al. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.
[10] W. Ray. Learning from aprotinin--mandatory trials of comparative efficacy and safety needed. , 2008, The New England journal of medicine.
[11] W. Ray,et al. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. , 2007, Gastroenterology.
[12] P. Vestergaard,et al. Fracture risk associated with the use of morphine and opiates , 2006, Journal of internal medicine.
[13] Joseph Loscalzo,et al. Cyclooxygenase inhibition and cardiovascular risk. , 2005, Circulation.
[14] J. Avorn,et al. Identification of individuals with CKD from Medicare claims data: a validation study. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] B. Gage,et al. Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors , 2005, Medical care.
[16] M. Hudson,et al. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. , 2005, Rheumatology.
[17] Sebastian Schneeweiss,et al. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. , 2004, American heart journal.
[18] M. Rocco,et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. , 2004, Kidney international.
[19] P. J. Bowman,et al. Central nervous system active medications and risk for fractures in older women. , 2003, Archives of internal medicine.
[20] A. Cheung,et al. Creatinine production, nutrition, and glomerular filtration rate estimation. , 2003, Journal of the American Society of Nephrology : JASN.
[21] A. Levin,et al. Canadian survey of clinical status at dialysis initiation 1998-1999: a multicenter prospective survey. , 2002, Clinical nephrology.
[22] P. J. Bowman,et al. Central Nervous System–Active Medications and Risk for Falls in Older Women , 2002, Journal of the American Geriatrics Society.
[23] F. Dekker,et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. , 2002, Kidney international.
[24] P. Hill,et al. Severe chronic renal failure in association with oxycodone addiction: a new form of fibrillary glomerulopathy. , 2002, Human pathology.
[25] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[26] D G Altman,et al. Confidence intervals for the number needed to treat , 1998, BMJ.
[27] P. Kerr,et al. Granulomatous glomerulonephritis in intravenous drug users: a report of three cases in oxycodone addicts. , 1998, Human pathology.
[28] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.
[29] Z. Ying,et al. Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .
[30] W. Ray,et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. , 1992, Journal of gerontology.
[31] W. Ray,et al. Identification of fractures from computerized Medicare files. , 1992, Journal of clinical epidemiology.
[32] M. Stagnitti. Trends in Outpatient Prescription Analgesics Utilization and Expenditures for the U.S. Civilian Noninstitutionalized Population, 1996 and 2006 , 2009 .
[33] J. Barkin. Risk of Peptic Ulcer Hospitalizations in Users of NSAIDs With Gastroprotective Cotherapy Versus Coxibs , 2008 .
[34] S. Berney. Cardiovascular Outcomes in New Users of Coxibs and Nonsteroidal Antiinflammatory Drugs: High-Risk Subgroups and Time Course of Risk , 2007 .
[35] M. Roe,et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE quality improvement initiative , 2006 .
[36] M. Pugsley. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. , 2002, Pharmacology & therapeutics.